non small cell lung cancer (nsclc)
Showing 1 - 25 of 31
Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)
Not yet recruiting
- Solid Tumors With HRAS Alterations
- +4 more
- (no location specified)
Aug 30, 2023
Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)
Active, not recruiting
- Metastatic
- +4 more
- Radiotherapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 6, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,
Recruiting
- Malignant Solid Tumor
- +5 more
- GEN1042
- +8 more
-
San Diego, California
- +27 more
Dec 24, 2022
Advanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ABBV-637, Docetaxel, Osimertinib)
Recruiting
- Advanced Solid Tumors Cancer
- Non Small Cell Lung Cancer (NSCLC)
- ABBV-637
- +2 more
-
Boston, Massachusetts
- +32 more
Dec 9, 2022
Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)
Completed
- Non Small Cell Lung Cancer (NSCLC)
- Malignant Pleural Mesothelioma (MPM)
-
Marseille, FranceAssistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022
Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)
Not yet recruiting
- Locally Advanced or Metastatic Solid Tumors
- +3 more
- (no location specified)
Jul 24, 2022
Non Small Cell Lung Cancer (NSCLC) Trial in Toronto (FLT-PET)
Active, not recruiting
- Non Small Cell Lung Cancer (NSCLC)
- FLT-PET
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 1, 2021
Non Small Cell Lung Cancer (NSCLC) Trial in Milan (Pembrolizumab)
Active, not recruiting
- Non Small Cell Lung Cancer (NSCLC)
-
Milan, ItalyNational Cancer Institute
Jun 8, 2021
Non Small Cell Lung Cancer (NSCLC) Trial in India (Osimertinib)
Completed
- Non Small Cell Lung Cancer (NSCLC)
-
Hyderabad, India
- +6 more
May 10, 2021
Non Small Cell Lung Cancer (NSCLC), Metastases to the Brain Trial in Pittsburgh (cabozantinib)
Terminated
- Non Small Cell Lung Cancer (NSCLC)
- Metastases to the Brain
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute- Hillman Cancer Center
Mar 8, 2021
Non Small Cell Lung Cancer (NSCLC) Trial in United States (Nab-Paclitaxel)
Completed
- Non Small Cell Lung Cancer (NSCLC)
-
Fayetteville, Arkansas
- +7 more
Sep 14, 2020
Non Small Cell Lung Cancer (NSCLC) Trial in Pittsburgh (semi-allogeneic human fibroblasts (MRC-5) transfected with DNA)
Terminated
- Non Small Cell Lung Cancer (NSCLC)
- semi-allogeneic human fibroblasts (MRC-5) transfected with DNA
-
Pittsburgh, Pennsylvania
- +1 more
Apr 10, 2019
Non Small Cell Lung Cancer (NSCLC) Trial in Maastricht (Nitroglycerin patch)
Terminated
- Non Small Cell Lung Cancer (NSCLC)
- Nitroglycerin patch
-
Maastricht, NetherlandsMAASTRO clinic
Feb 12, 2019
Non Small Cell Lung Cancer (NSCLC) Trial in Korea, Republic of, United States (Dacomitinib, Doxycycline, Probiotic)
Completed
- Non Small Cell Lung Cancer (NSCLC)
- Dacomitinib
- +3 more
-
Duarte, California
- +80 more
Dec 20, 2018
Non Small Cell Lung Cancer (NSCLC) Trial in Chapel Hill, Pittsburgh (Bavituximab)
Completed
- Non Small Cell Lung Cancer (NSCLC)
-
Chapel Hill, North Carolina
- +1 more
Dec 3, 2018
Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ZD1839 (Iressa))
Approved for marketing
- Non Small Cell Lung Cancer (NSCLC)
- ZD1839 (Iressa)
-
La Plata, Argentina
- +64 more
Sep 12, 2018
Renal Cancer, Non Small Cell Lung Cancer (NSCLC), Soft Tissue Sarcoma Trial in Charleston (Panobinostat (LBH589), Sorafenib)
Completed
- Renal Cancer
- +2 more
- Panobinostat (LBH589), Sorafenib
-
Charleston, South CarolinaMedical University of South Carolina Hollings Cancer Center
Feb 28, 2017
Non Small Cell Lung Cancer (NSCLC) Trial in United States (Cetuximab)
Completed
- Non Small Cell Lung Cancer (NSCLC)
-
Miami, Florida
- +30 more
Dec 7, 2016
Non Small Cell Lung Cancer (NSCLC), Intrathoracic Nodal Staging Trial in Amsterdam, Nijmegen, Krakow
Unknown status
- Non Small Cell Lung Cancer (NSCLC)
- Intrathoracic Nodal Staging
-
Amsterdam, Netherlands
- +3 more
Dec 15, 2016
Non Small Cell Lung Cancer (NSCLC), Radical Treatment, Stage III NSCLC Trial in Netherlands (Prophylactic Cranial Irradiation)
Completed
- Non Small Cell Lung Cancer (NSCLC)
- +2 more
- Prophylactic Cranial Irradiation
-
Maastricht, Limburg, Netherlands
- +8 more
Apr 9, 2015